市場調査レポート

商品コード

1363072

アスペルギルス症治療の市場規模、シェア、動向分析レポート：タイプ別、薬剤クラス別、投与経路別、流通チャネル別、地域別、セグメント予測、2023年～2030年

Aspergillosis Treatment Market Size, Share & Trends Analysis Report By Type (Allergic, Chronic, Invasive), By Drug Class (Antifungal), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

出版日: 2023年09月18日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 857,157円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,001,217円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,289,337円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

アスペルギルス症治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のアスペルギルス症治療市場規模は、2023年から2030年にかけて3.99%のCAGRを記録し、2030年までに57億9,000万米ドルに達する見込みです。

アスペルギルス症感染症、特に免疫不全者の罹患率の上昇は、革新的な治療アプローチの需要に拍車をかけています。医療技術と薬剤開発の急速な進歩は、より的を絞った効果的な治療法のイントロダクションつながり、患者の転帰と治療効果を高めています。認知度と診断能力の向上は早期発見と迅速な治療開始に貢献し、様々な薬剤に対する需要をさらに高めています。既存の治療パラダイムでは、抗生物質や副腎皮質ステロイドに加え、アゾール系抗真菌薬（イトラコナゾールやボリコナゾールなど）の使用が主流です。

F2G、TFFファーマシューティカルズ、Scynexis、Pulmocideなどの著名な企業が、侵襲性アスペルギルス症治療の展望を再構築する可能性を秘めた革新的な治療戦略の導入を進めています。このような候補薬の上市に成功すれば、この市場における既存の製薬企業のリーダーに対して大きな課題となる可能性があります。この課題は、確立された標準治療に革命をもたらし、それによって患者に革新的なアプローチを提供する能力から生じると思われます。

現在、企業や研究者は、研究開発（R&D）や治療の展望に影響を与える可能性のある課題を評価し、潜在的な機会を特定することに取り組んでいます。この分野で現在進行中の取り組みは、アスペルギルス症への対処と管理の強化を目指した革新的な戦略が中心となっています。例えば、パルマトリックス社は2022年4月、PUR1800を含む同社のナロースペクトラムキナーゼ阻害剤（NSKI）ポートフォリオの完全な権利回復を発表しました。

この決定は、ジョンソン・エンド・ジョンソンのエンタープライズ・イノベーション社が、パルマトリックス社と以前に締結したライセンシング、開発、商業化契約を終了すると決定した後に下されました。これを受けてパルマトリックス社は、PUR1800の開発を進める意向を明らかにしました。同社は、継続的な臨床評価と毒物学的研究を実施することにより、この化合物の進行を継続する予定です。これらの努力は、慢性閉塞性肺疾患（COPD）の急性増悪やその他の慢性呼吸器疾患に焦点を当てたプログラムを強化するために行われます。

アスペルギルス症治療市場レポートハイライト

タイプ別では、アレルギー性セグメントが2022年に最大の売上シェアを占めました。この成長は、特に喘息や嚢胞性線維症患者に影響を及ぼすアレルギー性気管支肺アスペルギルス症（ABPA）などの疾患において、有病率が高く、疾患の症状が軽いことに起因しています。
薬剤クラス別では、抗真菌薬セグメントが2022年に最大の売上シェアを占めました。この成長は、アスペルギルス症感染に対する有効性と、主要な治療オプションとしての幅広い使用によるものです。
投与経路に基づくと、経口薬セグメントは2022年に最大の収益シェアを占めました。この成長は、その利便性と患者に優しい投与方法によるもので、ヘルスケアプロバイダーと患者の両方にとって好ましい選択肢となっています。
流通チャネル別では、病院薬局セグメントが2022年に47.59%のシェアを占め、市場を独占しました。この成長は、アスペルギルス症治療薬の効果的な提供と入手のしやすさにおいて、病院を拠点とする流通チャネルが果たす極めて重要な役割によるものです。
2022年には北米が市場を独占しました。この優位性は、同地域の高度なヘルスケアインフラ、ダイナミックな研究開発（R&D）努力、最先端医療技術へのアクセスを強調する諸要因の合流に起因しています。

市場セグメンテーションと範囲
市場系統の見通し
- 親市場の見通し
- 関連/付随市場の見通し
市場動向と展望
市場力学
- アスペルギルス症の有病率の増加
- 医学調査の進歩
- 認識と診断の改善
市場抑制要因分析
- 限られた治療選択肢
- 高額な治療費
業界分析ツール
- ポーターのファイブフォース分析
- PESTEL分析
- COVID-19感染症の影響分析

第4章アスペルギルス症治療市場：タイプ別セグメント分析

アスペルギルス症治療：市場シェア分析、2022年および2030年
アレルギー性アスペルギルス症
慢性アスペルギルス症
侵襲性アスペルギルス症

第5章アスペルギルス症治療市場：医薬品別クラスセグメント分析

アスペルギルス症治療：市場シェア分析、2022年および2030年
抗真菌薬
その他

第6章アスペルギルス症治療市場：投与経路別セグメント分析

アスペルギルス症治療：市場シェア分析、2022年および2030年
経口薬
軟膏
粉末
その他

第7章アスペルギルス症治療市場：流通チャネル別セグメント分析別

アスペルギルス症治療：市場シェア分析、2022年および2030年
病院薬局
小売薬局
その他

第8章地域別ビジネス分析

地域別アスペルギルス症治療市場シェア、2022年および2030年
北米
- 北アスペルギルス症治療市場、2018年から2030年
- 米国
- カナダ
欧州
- 欧州のアスペルギルス症治療市場、2018年から2030年
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋地域
- アジア太平洋地域のアスペルギルス症治療市場、2018年から2030年
- 日本
- 中国
- インド
- オーストラリア
- タイ
- 韓国
ラテンアメリカ
- ラテンアメリカのアスペルギルス症治療市場、2018年から2030年
- ブラジル
- メキシコ
- アルゼンチン
中東・アフリカ
- SWOT分析
- MEAアスペルギルス症治療市場、2018年～2030年
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

企業の分類
戦略マッピング
企業の市場シェア分析、2022年
企業プロファイル・一覧表
- Pfizer, Inc
- Merck &Co
- F2G
- Novartis AG;
- Astellas Pharma Inc
- Bayer AG
- Mayne Pharma Group Limited
- PULMATRiX

図表

List of Tables

Table 1 List of abbreviations
Table 2 Global aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 3 Global aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 4 Global aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 5 Global aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 6 Global aspergillosis treatment market, by region, 2018 - 2030 (USD Million)
Table 7 North America aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 8 North America aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 9 North America aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 10 North America aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 11 North America aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 12 U.S. aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 13 U.S. aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 14 U.S. aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 15 U.S. aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 Canada aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 17 Canada aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 18 Canada aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 19 Canada aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 20 Europe aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 21 Europe aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 22 Europe aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 23 Europe aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 Europe aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 25 UK aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 26 UK aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 27 UK aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 28 UK aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 29 Germany aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 30 Germany aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 31 Germany aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 32 Germany aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 33 France aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 34 France aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 35 France aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 36 France aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 37 Italy aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 38 Italy aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 39 Italy aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 40 Italy aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 41 Spain aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 42 Spain aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 43 Spain aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 44 Spain aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 45 Denmark aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 46 Denmark aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 47 Denmark aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 48 Denmark aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 49 Sweden aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 50 Sweden aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 51 Sweden aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 52 Sweden aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 53 Norway aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 54 Norway aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 55 Norway aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 56 Norway aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 57 Asia Pacific aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 58 Asia Pacific aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 59 Asia Pacific aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 60 Asia Pacific aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 61 Asia Pacific aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 62 Asia Pacific aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 63 Japan aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 64 Japan aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 65 Japan aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 66 Japan aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 67 China aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 68 China aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 69 China aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 70 China aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 71 India aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 72 India aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 73 India aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 74 India aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 75 Australia aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 76 Australia aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 77 Australia aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 78 Australia aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 79 Thailand aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 80 Thailand aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 81 Thailand aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 82 Thailand aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 83 South Korea aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 84 South Korea aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 85 South Korea aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 86 South Korea aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 87 Latin America aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 88 Latin America aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 89 Latin America aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 90 Latin America aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 91 Latin America aspergillosis treatment market, by country, 2018 - 2030 (USD Million
Table 92 Brazil aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 93 Brazil aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 94 Brazil aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 95 Brazil aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 96 Mexico aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 97 Mexico aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 98 Mexico aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 99 Mexico aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 100 Argentina aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 101 Argentina aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 102 Argentina aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 103 Argentina aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 109 Middle East & Africa aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 110 South Africa aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 111 South Africa aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 112 South Africa aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 113 South Africa aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 117 Saudi Arabia aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 118 UAE aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 119 UAE aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 120 UAE aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 121 UAE aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 122 Kuwait aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 123 Kuwait aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 124 Kuwait aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 125 Kuwait aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Aspergillosis treatment market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market Trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 13 Porter's Five Forces analysis
Fig. 14 Market penetration & growth prospect mapping, 2022
Fig. 15 Global aspergillosis treatment market: By Type movement analysis
Fig. 16 Global aspergillosis treatment market, for allergic aspergillosis, 2018 - 2030 (USD Million)
Fig. 17 Global aspergillosis treatment market, for chronic aspergillosis, 2018 - 2030 (USD Million)
Fig. 18 Global aspergillosis treatment market, for invasive aspergillosis, 2018 - 2030 (USD Million)
Fig. 19 Global aspergillosis treatment market: Drug Class movement analysis
Fig. 20 Global aspergillosis treatment market, for antifungal drugs (Azoles, Echinocandins, Polyenes, Allylamines, Others) 2018 - 2030 (USD Million)
Fig. 21 Global aspergillosis treatment market, for others, 2018 - 2030 (USD Million)
Fig. 22 Global aspergillosis treatment market: Route of Administration movement analysis
Fig. 23 Global aspergillosis treatment market, for oral drugs, 2018 - 2030 (USD Million)
Fig. 24 Global aspergillosis treatment market, for ointments, 2018 - 2030 (USD Million)
Fig. 25 Global aspergillosis treatment market, for powders, 2018 - 2030 (USD Million)
Fig. 26 Global aspergillosis treatment market, for others, 2018 - 2030 (USD Million)
Fig. 27 Global aspergillosis treatment market: Distribution Chanel movement analysis
Fig. 28 Global aspergillosis treatment market, for hospital pharmacies, 2018 - 2030 (USD Million)
Fig. 29 Global aspergillosis treatment market, for retail pharmacy, 2018 - 2030 (USD Million)
Fig. 30 Global aspergillosis treatment market, for other pharmacies, 2018 - 2030 (USD Million)
Fig. 31 Regional marketplace: Key takeaways
Fig. 32 Regional outlook, 2022 & 2030
Fig. 33 Global aspergillosis treatment market: Region movement analysis
Fig. 34 North America aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 35 U.S. aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 36 Canada aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 37 Europe aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 38 Germany aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 39 UK aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 40 France aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 41 Italy aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 42 Spain aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 43 Denmark aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 44 Sweden aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 45 Norway aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 46 Asia Pacific aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 47 Japan aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 48 China aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 49 India aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 50 Australia aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 51 South Korea aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 52 Thailand aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 53 Latin America aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 54 Brazil aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 55 Mexico aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 56 Argentina aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 57 Middle East and Africa aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 58 South Africa aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 59 Saudi Arabia aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 60 UAE aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 61 Kuwait aspergillosis treatment market, 2018 - 2030 (USD Million)

Product Code: GVR-4-68040-123-2

Aspergillosis Treatment Market Growth & Trends:

The global aspergillosis treatment market size is expected to reach USD 5.79 billion by 2030, registering a CAGR of 3.99% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The rising incidence of aspergillosis infections, particularly among immunocompromised individuals, has spurred the demand for innovative treatment approaches. Rapid advancements in medical technology and drug development have led to the introduction of more targeted and effective therapies, enhancing patient outcomes and treatment efficacy. Improved awareness and diagnostic capabilities contribute to early detection and prompt treatment initiation, further increasing the demand for various drugs. The existing treatment paradigm predominantly relies on the utilization of conventional antifungal drugs such as azoles (such as Itraconazole and voriconazole), in addition to antibiotics and corticosteroids.

Several prominent companies such as F2G, TFF Pharmaceuticals, Scynexis, and Pulmocide are in the process of introducing innovative therapeutic strategies that hold the potential to reshape the landscape of Invasive Aspergillosis treatment. The successful launch of such candidates could pose a substantial challenge to the established pharmaceutical leaders in the market. This challenge would arise from their capacity to revolutionize the established standard of care, thereby offering a transformative approach for patients.

Companies and researchers are currently engaged in evaluating challenges and identifying potential opportunities that could impact the research and development (R&D) and treatment landscape. The ongoing efforts in this field are centered around innovative strategies aimed at addressing and enhancing the management of Aspergillosis. For instance, in April 2022, Pulmatrix announced the restoration of complete rights to its portfolio of narrow-spectrum kinase inhibitors (NSKIs), which includes PUR1800.

This decision came about after the determination by Johnson & Johnson's Enterprise Innovation to terminate the licensing, development, and commercialization agreement previously established with Pulmatrix. In response, Pulmatrix has outlined its intention to proceed with the advancement of PUR1800. The company plans to continue the progression of this compound by conducting continuous clinical assessments and toxicology studies. These endeavors are undertaken to bolster programs focused on acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD) as well as other chronic respiratory conditions.

Aspergillosis Treatment Market Report Highlights:

Based on type, the allergic segment held the largest revenue share in 2022, the growth can be attributed to higher prevalence and milder disease presentation, particularly in conditions such as allergic bronchopulmonary aspergillosis (ABPA) affecting asthma and cystic fibrosis patients
Based on drug class, the antifungal drug segment held the largest revenue share in 2022, the growth can be attributed to their effectiveness in combating aspergillosis infections and their wide usage as a primary treatment option
Based on route of administration, the oral drugs segment held the largest revenue share in 2022. This growth is due to its convenience and patient-friendly administration, making it a preferred choice for both healthcare providers and patients
Based on distribution channel, the hospital pharmacy segment dominated the market with a share of 47.59% in 2022. This growth is due to the pivotal role that hospital-based distribution channels play in the effective delivery and accessibility of treatments for aspergillosis
North America dominated the market in 2022. This dominance can be attributed to a confluence of factors that underscore the region's advanced healthcare infrastructure, dynamic research and development (R&D) endeavors, access to cutting-edge medical technologies

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
  - 1.1.1.1. Type Segment
  - 1.1.1.2. Drug Class
  - 1.1.1.3. Route of Administration
  - 1.1.1.4. Distribution Channel
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
- 1.4.1. Objective 1
- 1.4.2. Objective2
- 1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
- 1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
- 3.4.1. Increasing Prevalence of Aspergillosis
- 3.4.2. Advancements in Medical Research
- 3.4.3. Awareness and Diagnosis Improvement
3.5. Market Restraint Analysis
- 3.5.1. Limited Treatment Options
- 3.5.2. High Treatment Costs
3.6. Industry Analysis Tools
- 3.6.1. Porter's Five Forces Analysis
- 3.6.2. PESTEL Analysis
- 3.6.3. COVID-19 Impact Analysis

Chapter 4. Aspergillosis Treatment Market: By Type Segment Analysis

4.1. Aspergillosis Treatment: Market Share Analysis, 2022 & 2030
4.2. Allergic Aspergillosis
- 4.2.1. Allergic Aspergillosis Market, 2018 - 2030 (USD Million)
4.3. Chronic Aspergillosis
- 4.3.1. Chronic Aspergillosis Market, 2018 - 2030 (USD Million)
4.4. Invasive Aspergillosis
- 4.4.1. Invasive Aspergillosis Market, 2018 - 2030 (USD Million)

Chapter 5. Aspergillosis Treatment Market: Drug Class Segment Analysis

5.1. Aspergillosis Treatment: Market Share Analysis, 2022 & 2030
5.2. Antifungal Drugs
- 5.2.1. Antifungal Drugs Market, 2018 - 2030 (USD Million)
  - 5.2.1.1. Azoles
  - 5.2.1.2. Echinocandins
  - 5.2.1.3. Polyenes
  - 5.2.1.4. Allylamines
  - 5.2.1.5. Others
5.3. Others
- 5.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Aspergillosis Treatment Market: Route of Administration Segment Analysis

6.1. Aspergillosis Treatment: Market Share Analysis, 2022 & 2030
6.2. Oral Drugs
- 6.2.1. Oral Drugs Market, 2018 - 2030 (USD Million)
6.3. Ointments
- 6.3.1. Ointments Market, 2018 - 2030 (USD Million)
6.4. Powders
- 6.4.1. Powders Market, 2018 - 2030 (USD Million)
6.5. Others
- 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Aspergillosis Treatment Market: By Distribution Channel Segment Analysis

7.1. Aspergillosis Treatment: Market Share Analysis, 2022 & 2030
7.2. Hospital Pharmacy
- 7.2.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
7.3. Retail Pharmacy
- 7.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
7.4. Others
- 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

8.1. Aspergillosis Treatment Market Share By Region, 2022 & 2030
8.2. North America
- 8.2.1. North Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
  - 8.2.2.1. Key Country Dynamics
  - 8.2.2.2. Competitive Scenario
  - 8.2.2.3. Regulatory Framework
  - 8.2.2.4. U.S. Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.2.3. Canada
  - 8.2.3.1. Key Country Dynamics
  - 8.2.3.2. Competitive Scenario
  - 8.2.3.3. Regulatory Framework
  - 8.2.3.4. Canada Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
8.3. Europe
- 8.3.1. Europe Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.3.2. UK
  - 8.3.2.1. Key Country Dynamics
  - 8.3.2.2. Competitive Scenario
  - 8.3.2.3. Regulatory Framework
  - 8.3.2.4. UK Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.3.3. Germany
  - 8.3.3.1. Key Country Dynamics
  - 8.3.3.2. Competitive Scenario
  - 8.3.3.3. Regulatory Framework
  - 8.3.3.4. Germany Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.3.4. France
  - 8.3.4.1. Key Country Dynamics
  - 8.3.4.2. Competitive Scenario
  - 8.3.4.3. Regulatory Framework
  - 8.3.4.4. France Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.3.5. Italy
  - 8.3.5.1. Key Country Dynamics
  - 8.3.5.2. Competitive Scenario
  - 8.3.5.3. Regulatory Framework
  - 8.3.5.4. Italy Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.3.6. Spain
  - 8.3.6.1. Key Country Dynamics
  - 8.3.6.2. Competitive Scenario
  - 8.3.6.3. Regulatory Framework
  - 8.3.6.4. Spain Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.3.7. Denmark
  - 8.3.7.1. Key Country Dynamics
  - 8.3.7.2. Competitive Scenario
  - 8.3.7.3. Regulatory Framework
  - 8.3.7.4. Denmark Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.3.8. Sweden
  - 8.3.8.1. Key Country Dynamics
  - 8.3.8.2. Competitive Scenario
  - 8.3.8.3. Regulatory Framework
  - 8.3.8.4. Sweden Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.3.9. Norway
  - 8.3.9.1. Key Country Dynamics
  - 8.3.9.2. Competitive Scenario
  - 8.3.9.3. Regulatory Framework
  - 8.3.9.4. Norway Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
- 8.4.1. Asia Pacific Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.4.2. Japan
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Competitive Scenario
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. Japan Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.4.3. China
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Competitive Scenario
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. China Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.4.4. India
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Competitive Scenario
  - 8.4.4.3. Regulatory Framework
  - 8.4.4.4. India Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.4.5. Australia
  - 8.4.5.1. Key Country Dynamics
  - 8.4.5.2. Competitive Scenario
  - 8.4.5.3. Regulatory Framework
  - 8.4.5.4. Australia Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.4.6. Thailand
  - 8.4.6.1. Key Country Dynamics
  - 8.4.6.2. Competitive Scenario
  - 8.4.6.3. Regulatory Framework
  - 8.4.6.4. Thailand Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.4.7. South Korea
  - 8.4.7.1. Key Country Dynamics
  - 8.4.7.2. Competitive Scenario
  - 8.4.7.3. Regulatory Framework
  - 8.4.7.4. South Korea Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
8.5. Latin America
- 8.5.1. Latin America Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Target Disease Prevalence
  - 8.5.2.3. Competitive Scenario
  - 8.5.2.4. Regulatory Framework
  - 8.5.2.5. Brazil Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.5.3. Mexico
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. Mexico Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.5.4. Argentina
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Competitive Scenario
  - 8.5.4.3. Regulatory Framework
  - 8.5.4.4. Argentina Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
8.6. MEA
- 8.6.1. SWOT Analysis
- 8.6.2. MEA Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.6.3. South Africa
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. South Africa Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.6.4. Saudi Arabia
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Competitive Scenario
  - 8.6.4.3. Regulatory Framework
  - 8.6.4.4. Saudi Arabia Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.6.5. UAE
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Competitive Scenario
  - 8.6.5.3. Regulatory Framework
  - 8.6.5.4. UAE Aspergillosis Treatment Market, 2018 - 2030 (USD Million)
- 8.6.6. Kuwait
  - 8.6.6.1. Key Country Dynamics
  - 8.6.6.2. Competitive Scenario
  - 8.6.6.3. Regulatory Framework
  - 8.6.6.4. Kuwait Aspergillosis Treatment Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
- 9.4.1. Pfizer, Inc
  - 9.4.1.1. Overview
  - 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Strategic Initiatives
- 9.4.2. Merck & Co
  - 9.4.2.1. Overview
  - 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Strategic Initiatives
- 9.4.3. F2G
  - 9.4.3.1. Overview
  - 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Strategic Initiatives
- 9.4.4. Novartis AG;
  - 9.4.4.1. Overview
  - 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Strategic Initiatives
- 9.4.5. Astellas Pharma Inc
  - 9.4.5.1. Overview
  - 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Strategic Initiatives
- 9.4.6. Bayer AG
  - 9.4.6.1. Overview
  - 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Strategic Initiatives
- 9.4.7. Mayne Pharma Group Limited
  - 9.4.7.1. Overview
  - 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Strategic Initiatives
- 9.4.8. PULMATRiX
  - 9.4.8.1. Overview
  - 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Strategic Initiatives

アスペルギルス症治療の市場規模、シェア、動向分析レポート：タイプ別、薬剤クラス別、投与経路別、流通チャネル別、地域別、セグメント予測、2023年～2030年

Aspergillosis Treatment Market Size, Share & Trends Analysis Report By Type (Allergic, Chronic, Invasive), By Drug Class (Antifungal), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

アスペルギルス症治療市場の成長と動向：

アスペルギルス症治療市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章市場変数、動向、および範囲

第4章アスペルギルス症治療市場：タイプ別セグメント分析

第5章アスペルギルス症治療市場：医薬品別クラスセグメント分析

第6章アスペルギルス症治療市場：投与経路別セグメント分析

第7章アスペルギルス症治療市場：流通チャネル別セグメント分析別

第8章地域別ビジネス分析

第9章競合情勢

List of Tables

List of Figures

Aspergillosis Treatment Market Growth & Trends:

Aspergillosis Treatment Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Aspergillosis Treatment Market: By Type Segment Analysis

Chapter 5. Aspergillosis Treatment Market: Drug Class Segment Analysis

Chapter 6. Aspergillosis Treatment Market: Route of Administration Segment Analysis

Chapter 7. Aspergillosis Treatment Market: By Distribution Channel Segment Analysis

Chapter 8. Regional Business Analysis

Chapter 9. Competitive Landscape

アスペルギルス症治療の市場規模、シェア、動向分析レポート：タイプ別、薬剤クラス別、投与経路別、流通チャネル別、地域別、セグメント予測、2023年～2030年

Aspergillosis Treatment Market Size, Share & Trends Analysis Report By Type (Allergic, Chronic, Invasive), By Drug Class (Antifungal), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

アスペルギルス症治療市場の成長と動向：

アスペルギルス症治療市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

第4章 アスペルギルス症治療市場：タイプ別セグメント分析

第5章 アスペルギルス症治療市場：医薬品別クラスセグメント分析

第6章 アスペルギルス症治療市場：投与経路別セグメント分析

第7章 アスペルギルス症治療市場：流通チャネル別セグメント分析別

第8章 地域別ビジネス分析

第9章 競合情勢

List of Tables

List of Figures

Aspergillosis Treatment Market Growth & Trends:

Aspergillosis Treatment Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Aspergillosis Treatment Market: By Type Segment Analysis

Chapter 5. Aspergillosis Treatment Market: Drug Class Segment Analysis

Chapter 6. Aspergillosis Treatment Market: Route of Administration Segment Analysis

Chapter 7. Aspergillosis Treatment Market: By Distribution Channel Segment Analysis

Chapter 8. Regional Business Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章市場変数、動向、および範囲

第4章アスペルギルス症治療市場：タイプ別セグメント分析

第5章アスペルギルス症治療市場：医薬品別クラスセグメント分析

第6章アスペルギルス症治療市場：投与経路別セグメント分析

第7章アスペルギルス症治療市場：流通チャネル別セグメント分析別

第8章地域別ビジネス分析

第9章競合情勢